1. Home
  2. PCVX vs CHX Comparison

PCVX vs CHX Comparison

Compare PCVX & CHX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCVX
  • CHX
  • Stock Information
  • Founded
  • PCVX 2013
  • CHX 1882
  • Country
  • PCVX United States
  • CHX United States
  • Employees
  • PCVX N/A
  • CHX N/A
  • Industry
  • PCVX Biotechnology: Pharmaceutical Preparations
  • CHX Industrial Machinery/Components
  • Sector
  • PCVX Health Care
  • CHX Industrials
  • Exchange
  • PCVX Nasdaq
  • CHX Nasdaq
  • Market Cap
  • PCVX 4.4B
  • CHX 4.7B
  • IPO Year
  • PCVX 2020
  • CHX N/A
  • Fundamental
  • Price
  • PCVX $33.27
  • CHX $26.43
  • Analyst Decision
  • PCVX Strong Buy
  • CHX Strong Buy
  • Analyst Count
  • PCVX 10
  • CHX 3
  • Target Price
  • PCVX $136.50
  • CHX $37.67
  • AVG Volume (30 Days)
  • PCVX 1.5M
  • CHX 3.2M
  • Earning Date
  • PCVX 08-05-2025
  • CHX 07-23-2025
  • Dividend Yield
  • PCVX N/A
  • CHX 1.45%
  • EPS Growth
  • PCVX N/A
  • CHX N/A
  • EPS
  • PCVX N/A
  • CHX 1.51
  • Revenue
  • PCVX N/A
  • CHX $3,576,306,000.00
  • Revenue This Year
  • PCVX N/A
  • CHX N/A
  • Revenue Next Year
  • PCVX N/A
  • CHX $3.56
  • P/E Ratio
  • PCVX N/A
  • CHX $17.37
  • Revenue Growth
  • PCVX N/A
  • CHX N/A
  • 52 Week Low
  • PCVX $27.66
  • CHX $21.92
  • 52 Week High
  • PCVX $121.06
  • CHX $35.94
  • Technical
  • Relative Strength Index (RSI)
  • PCVX 46.99
  • CHX 59.92
  • Support Level
  • PCVX $32.00
  • CHX $24.60
  • Resistance Level
  • PCVX $34.63
  • CHX $26.60
  • Average True Range (ATR)
  • PCVX 1.31
  • CHX 0.71
  • MACD
  • PCVX -0.08
  • CHX 0.04
  • Stochastic Oscillator
  • PCVX 37.46
  • CHX 82.11

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.

About CHX ChampionX Corporation

ChampionX provides chemical solutions and equipment for onshore and offshore oil and gas production. Its engineering expertise spans the well lifecycle, but the firm maintains a particular focus on the production phase. Key offerings include artificial lift services and drilling technologies, specializing in polycrystalline diamond cutter inserts. ChampionX was formed after Apergy acquired its chemical technologies business from Ecolab in 2020.

Share on Social Networks: